Literature DB >> 23253442

Development of a long acting human growth hormone analog suitable for once a week dosing.

Moorthy S S Palanki1, Abhijit Bhat, Ben Bolanos, Florence Brunel, Joselyn Del Rosario, Danielle Dettling, Mark Horn, Rodney Lappe, Ryan Preston, Annette Sievers, Nebojsa Stankovic, Gary Woodnut, Gang Chen.   

Abstract

Human growth hormone was conjugated to a carrier aldolase antibody, using a novel linker by connecting a disulphide bond in growth hormone to a lysine-94 amine located on the Fab arm of the antibody. The resulting CovX body showed reduced affinity towards human growth hormone receptor, reduced cell-based activity, but improved pharmacodynamic properties. We have demonstrated that this CovX-body, given once a week, showed comparable activity as growth hormone given daily in an in vivo hypophysectomized rat model.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23253442     DOI: 10.1016/j.bmcl.2012.11.104

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Chemically programmed antibodies.

Authors:  Christoph Rader
Journal:  Trends Biotechnol       Date:  2014-03-11       Impact factor: 19.536

2.  Homogeneous bispecifics by disulfide bridging.

Authors:  Elizabeth A Hull; Maria Livanos; Enrique Miranda; Mark E B Smith; Kerry A Chester; James R Baker
Journal:  Bioconjug Chem       Date:  2014-08-01       Impact factor: 4.774

3.  A novel approach to the site-selective dual labelling of a protein via chemoselective cysteine modification.

Authors:  Ramiz I Nathani; Paul Moody; Vijay Chudasama; Mark E B Smith; Richard J Fitzmaurice; Stephen Caddick
Journal:  Chem Sci       Date:  2013-06-18       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.